NCT00544570View on ClinicalTrials.gov

High-Dose Chemotherapy in Treating Patients Undergoing Stem Cell Transplant for Recurrent or Refractory Hodgkin's Lymphoma

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Lymphoma
Interventions
BIOLOGICAL

filgrastim

DRUG

carmustine

DRUG

cyclophosphamide

DRUG

etoposide

DRUG

melphalan

PROCEDURE

autologous hematopoietic stem cell transplantation

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

radiation therapy

RADIATION

total-body irradiation

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00544570 - High-Dose Chemotherapy in Treating Patients Undergoing Stem Cell Transplant for Recurrent or Refractory Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter